Literature DB >> 16546587

Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate.

Stine Regin Wiegell1, Hans Christian Wulf.   

Abstract

BACKGROUND: Recent studies have shown that photodynamic therapy (PDT) is effective in the treatment of acne vulgaris. No studies have compared the treatment effect of aminolevulinic acid-PDT (ALA-PDT) and methyl aminolevulinate-PDT (MAL-PDT).
OBJECTIVE: We sought to compare the treatment effect and tolerability of ALA-PDT versus MAL-PDT in the treatment of acne vulgaris in a controlled randomized investigator-blinded trial.
METHODS: Fifteen patients with at least 12 facial inflammatory acne lesions had one split-face PDT treatment with MAL and ALA.
RESULTS: Twelve weeks after treatment we found a 59% decrease in inflammatory lesions from baseline, with no significant differences in effectiveness between the two treatments. All patients experienced moderate to severe pain during illumination and developed erythema, pustular eruptions, and epithelial exfoliation after treatment, which were more severe and uniform in the ALA-PDT-treated area. LIMITATIONS: The study is paired and controlled, but the results should be evaluated with consideration given for the number of participating patients.
CONCLUSION: PDT appeared to be an effective treatment for inflammatory acne vulgaris with no significant differences in the response rate between ALA-PDT and MAL-PDT. ALA-PDT resulted in more prolonged and severe adverse effects after treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546587     DOI: 10.1016/j.jaad.2005.12.033

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  25 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Therapeutic and Aesthetic Uses of Photodynamic Therapy Part five of a five-part series: ALA-PDT and MAL-PDT What Makes Them Different.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2009-02

3.  Laser treatment of acne vulgaris.

Authors:  Ming H Jih; Arash Kimyai-Asadi
Journal:  Semin Plast Surg       Date:  2007-08       Impact factor: 2.314

4.  [Physical treatment methods for acne. Light, laser, photodynamic therapy and peeling].

Authors:  C Borelli; H C Korting
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

Review 5.  Photodynamic therapy in dermatology: a review.

Authors:  Sonal Choudhary; Keyvan Nouri; Mohamed L Elsaie
Journal:  Lasers Med Sci       Date:  2009-08-05       Impact factor: 3.161

Review 6.  Photodynamic Therapy and Skin Appendage Disorders: A Review.

Authors:  Matteo Megna; Gabriella Fabbrocini; Claudio Marasca; Giuseppe Monfrecola
Journal:  Skin Appendage Disord       Date:  2016-12-08

7.  Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)-induced PpIX production for topical photodynamic therapy without increase in pain or erythema.

Authors:  Patrycja Mikolajewska; Ryan F Donnelly; Martin J Garland; Desmond I J Morrow; Thakur Raghu Raj Singh; Vladimir Iani; Johan Moan; Asta Juzeniene
Journal:  Pharm Res       Date:  2010-07-31       Impact factor: 4.200

Review 8.  Photodynamic therapy for infections: clinical applications.

Authors:  Gitika B Kharkwal; Sulbha K Sharma; Ying-Ying Huang; Tianhong Dai; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

Review 9.  Photodynamic therapy for localized infections--state of the art.

Authors:  Tianhong Dai; Ying-Ying Huang; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2009 Sep-Dec       Impact factor: 3.631

Review 10.  Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.

Authors:  Christine B Warren; Laszlo J Karai; Allison Vidimos; Edward V Maytin
Journal:  J Am Acad Dermatol       Date:  2009-12       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.